adenosine deaminase
Ultimo aggiornamento 21 May 2024
Rispetta le linee guida editoriali
- ScaricaScarica
- Condividi
- Language
- Discussione
- Ask Patient
- Versione audio
- Aggiungi alle fonti preferite su Google
The ADA gene provides instructions for producing the enzyme adenosine deaminase. This enzyme is produced in all cells, but the highest levels of adenosine deaminase are found in immune system cells called lymphocytes. These cells defend the body against foreign invaders, such as viruses or bacteria. Lymphocytes are produced in specialized lymphoid tissues throughout the body, including in a gland located behind the breastbone called the thymus and in the lymph nodes.
Scelte video per GenesVideo library
Normal function
The ADA gene provides instructions for producing the enzyme adenosine deaminase. This enzyme is produced in all cells, but the highest levels of adenosine deaminase are found in immune system cells called lymphocytes. These cells defend the body against foreign invaders, such as viruses or bacteria. Lymphocytes are produced in specialized lymphoid tissues throughout the body, including in a gland located behind the breastbone called the thymus and in the lymph nodes.
The function of the adenosine deaminase enzyme is to get rid of a molecule called deoxyadenosine, which is generated when DNA is broken down. A buildup of deoxyadenosine in cells can lead to early cell death. Adenosine deaminase converts deoxyadenosine to another molecule called deoxyinosine, which is not harmful.
Conditions referring to this gene or chromosome
Altri nomi
ADA_HUMAN
adenosine aminohydrolase
Related patient information and medicines

Patient information leaflet
Sindrome di Wolff-Parkinson-White
Sindrome di Wolff-Parkinson-White is not common but can cause a fast heart rate or other heart rhythm abnormalities from time to time. Treatment can be given ... If an episode of SVT lasts a long time or is severe, you may need to be admitted to hospital. Medicines can be used to stop an episode of TSV - eg, adenosine. Electric shock treatment.

Patient information leaflet
Tachicardia sopraventricolare
Some people can stop ... If you are diagnosed with SVT you are likely to be taught these manoeuvres. Medical help. You may need to be admitted to hospital to stop it. In hospital they may use: Medicine. A medicine called adenosine is given by injection into a vein. It usually stops SVT. It works by blocking electrical impulses in the heart..

Patient information leaflet
Posso prendere Chaga e Cordyceps insieme?
Caffeina Cordyceps may have mild stimulant properties and can interact with adenosine receptors. Combining it with caffeine (coffee, tea, energy drinks) may increase heart rate, jitteriness, or palpitations in sensitive individuals. Using other medicines Taking multiple medicines. Our Medicines Interaction Checker helps you check whether your.

Patient information leaflet
Inibitori della pompa protonica
T... By decreasing the amount of acid, they can also help to reduce acid reflux-related symptoms such as heartburn. They are called 'proton pump inhibitors' because they work by blocking (inhibiting) a chemical system called the hydrogen-potassium adenosine triphosphatase enzyme system (otherwise known as the 'proton pump'). This chemical system.
Ulteriori letture e riferimenti
- adenosine deaminase; MedlinePlus, National Library of Medicine.
- Blackburn MR, Thompson LF. Adenosine deaminase deficiency: unanticipated benefits from the study of a rare immunodeficiency. J Immunol. 2012 Feb 1;188(3):933-5. doi: 10.4049/jimmunol.1103519. No abstract available.
- Ferrua F, Aiuti A. Twenty-Five Years of Gene Therapy for ADA-SCID: From Bubble Babies to an Approved Drug. Hum Gene Ther. 2017 Nov;28(11):972-981. doi: 10.1089/hum.2017.175.
- Hershfield M, Tarrant T. Adenosine Deaminase Deficiency. 2006 Oct 3 [updated 2025 Dec 4]. In: Adam MP, Bick S, Mirzaa GM, Wallace SE, Amemiya A, editors. GeneReviews(R) [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2026. Available from http://www.ncbi.nlm.nih.gov/books/NBK1483/
- Hershfield MS. Genotype is an important determinant of phenotype in adenosine deaminase deficiency. Curr Opin Immunol. 2003 Oct;15(5):571-7. doi: 10.1016/s0952-7915(03)00104-3.
- Hershfield MS. New insights into adenosine-receptor-mediated immunosuppression and the role of adenosine in causing the immunodeficiency associated with adenosine deaminase deficiency. Eur J Immunol. 2005 Jan;35(1):25-30. doi: 10.1002/eji.200425738.
- Nyhan WL. Disorders of purine and pyrimidine metabolism. Mol Genet Metab. 2005 Sep-Oct;86(1-2):25-33. doi: 10.1016/j.ymgme.2005.07.027.
Storia dell'articolo
Articolo disponibile anche in Inglese, Tedesco, Spagnolo, Francese, Italiano, Portoghese, Hindi, Ebraico, Arabo, and Svedese.
21 May 2024 | Ultima versione
1 maggio 2024 | Pubblicato originariamente
Condividi i tuoi pensieri o esperienze con gli altri nel nostro comunità di pazienti.
Iscriviti alla newsletter di Patient
La tua dose settimanale di consigli sulla salute chiari e affidabili - scritti per aiutarti a sentirti informato, sicuro e in controllo.
Abbonandoti accetti i nostri Informativa sulla Privacy. Puoi annullare l'iscrizione in qualsiasi momento. Non vendiamo mai i tuoi dati.

